Raffaella Bitossi

559 total citations
21 papers, 442 citations indexed

About

Raffaella Bitossi is a scholar working on Oncology, Dermatology and Hepatology. According to data from OpenAlex, Raffaella Bitossi has authored 21 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 4 papers in Dermatology and 4 papers in Hepatology. Recurrent topics in Raffaella Bitossi's work include Colorectal Cancer Treatments and Studies (11 papers), Cancer Treatment and Pharmacology (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Raffaella Bitossi is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Cancer Treatment and Pharmacology (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Raffaella Bitossi collaborates with scholars based in Italy, United Kingdom and United States. Raffaella Bitossi's co-authors include Luigi Dogliotti, G. Gorzegno, Alfredo Berruti, Dario Fontana, G. Fasolis, F. Porpiglia, Maurizio Bellina, M. Torta, Alberto Angeli and Marco Tampellini and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and The Journal of Urology.

In The Last Decade

Raffaella Bitossi

20 papers receiving 426 citations

Peers

Raffaella Bitossi

ONCOL

PRM

CR

SURGE

RNMI

Lea Latham Italy

Jing-Xian Shen China

Timothy F. Shepard United States

Norisuke Shibuya Japan

Xiaobo He China

Paolo Montemaggi Italy

Jamil Asselah Canada

Changli Wang China

Sue Chua United Kingdom

Annelies Verbiest Belgium

Lea Latham Italy

Raffaella Bitossi

163 ×0.5

ONCOL

173 ×0.9

PRM

84 ×0.9

CR

60 ×0.6

SURGE

59 ×0.6

RNMI

Citations per year, relative to Raffaella Bitossi Raffaella Bitossi (= 1×) peers Lea Latham

Countries citing papers authored by Raffaella Bitossi

Since Specialization

Citations

This map shows the geographic impact of Raffaella Bitossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaella Bitossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaella Bitossi more than expected).

Fields of papers citing papers by Raffaella Bitossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaella Bitossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaella Bitossi. The network helps show where Raffaella Bitossi may publish in the future.

Co-authorship network of co-authors of Raffaella Bitossi

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaella Bitossi. A scholar is included among the top collaborators of Raffaella Bitossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaella Bitossi. Raffaella Bitossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Tampellini, Marco, Chiara Baratelli, Raffaella Bitossi, et al.. (2015). Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy. Chronobiology International. 32(10). 1359–1366. 1 indexed citations

2.

Baratelli, Chiara, et al.. (2014). Acute and fatal thrombocytopenic thrombotic purpura after a single dose of pemetrexed. International Journal of Clinical Pharmacy. 36(6). 1141–1143. 3 indexed citations

3.

Bellini, Elisa, Annamaria Ferrero, Chiara Baratelli, et al.. (2013). A case of long-term survival after repeated response to oxaliplatin-based chemotherapy and repeated thermoablation of liver metastases from colorectal cancer. Should we introduce the concept of oxaliplatin-resistant tumors?. Tumori Journal. 99(3). e91–e95. 2 indexed citations

4.

Bellini, Elisa, Annamaria Ferrero, Chiara Baratelli, et al.. (2013). A case of long-term survival after repeated response to oxaliplatin-based chemotherapy and repeated thermoablation of liver metastases from colorectal cancer. Should we introduce the concept of oxaliplatin-resistant tumors?. PubMed. 99(3). e91–5. 2 indexed citations

5.

Tampellini, Marco, Elisa Bellini, Chiara Baratelli, et al.. (2012). The Role of Lung Metastasis Resection in Improving Outcome of Colorectal Cancer Patients: Results From a Large Retrospective Study. The Oncologist. 17(11). 1430–1438. 60 indexed citations

6.

Bitossi, Raffaella, Marco Tampellini, Maria Pia Brizzi, et al.. (2009). Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients.. PubMed. 28(5B). 3055–60. 16 indexed citations

7.

Tampellini, Marco, Maria Pia Brizzi, Raffaella Bitossi, et al.. (2007). Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy. Journal of Cancer Research and Clinical Oncology. 133(10). 783–785. 2 indexed citations

8.

Saini, Andrea, Alfredo Berruti, Paola Sperone, et al.. (2006). Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation. The Lancet Oncology. 7(2). 186–187. 5 indexed citations

9.

Tampellini, Marco, Alfredo Berruti, Raffaella Bitossi, et al.. (2006). Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients. Breast Cancer Research and Treatment. 98(3). 241–248. 29 indexed citations

10.

Tampellini, Marco, Andrea Saini, Raffaella Bitossi, et al.. (2006). The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients. British Journal of Cancer. 95(1). 13–20. 24 indexed citations

11.

Tampellini, Marco, Susanna Cappia, Elisa Bacillo, et al.. (2006). TGFalfa, EGFR and p70S6K expression in aggressive colorectal cancer (CRC). Journal of Clinical Oncology. 24(18_suppl). 13505–13505. 1 indexed citations

12.

Berruti, Alfredo, Alessandra Mosca, Raffaella Bitossi, et al.. (2006). Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients.. PubMed. 25(6C). 4475–9. 2 indexed citations

13.

Berruti, Alfredo, Raffaella Bitossi, G. Gorzegno, et al.. (2005). Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines. British Journal of Cancer. 92(4). 634–638. 8 indexed citations

14.

Berruti, Alfredo, Raffaella Bitossi, Alberto Bottini, et al.. (2004). Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naïve metastatic breast cancer patients. European Journal of Cancer. 41(2). 249–255. 7 indexed citations

15.

Tampellini, Marco, Andrea Saini, Raffaella Bitossi, et al.. (2004). The role of hemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer (ACC) patients. Journal of Clinical Oncology. 22(14_suppl). 3564–3564. 1 indexed citations

16.

Tampellini, Marco, Andrea Saini, Raffaella Bitossi, et al.. (2004). The role of hemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer (ACC) patients. Journal of Clinical Oncology. 22(14_suppl). 3564–3564. 2 indexed citations

17.

Tampellini, Marco, Raffaella Bitossi, Maria Pia Brizzi, et al.. (2004). Pharmacoeconomic Comparison between Chronochemotherapy and Folfox Regimen in the Treatment of Patients with Metastatic Colorectal Cancer: A Cost-Minimization Study. Tumori Journal. 90(1). 44–49. 7 indexed citations

18.

Berruti, Alfredo, Raffaella Bitossi, G. Gorzegno, et al.. (2002). Time to Progression in Metastatic Breast Cancer Patients Treated With Epirubicin Is Not Improved by the Addition of Either Cisplatin or Lonidamine: Final Results of a Phase III Study With a Factorial Design. Journal of Clinical Oncology. 20(20). 4150–4159. 74 indexed citations

19.

Tampellini, Marco, Alfredo Berruti, G. Gorzegno, et al.. (2001). Independent Factors Predict Supranormal CA 15-3 Serum Levels in Advanced Breast Cancer Patients at First Disease Relapse. Tumor Biology. 22(6). 367–373. 14 indexed citations

20.

Berruti, Alfredo, Luigi Dogliotti, Raffaella Bitossi, et al.. (2000). INCIDENCE OF SKELETAL COMPLICATIONS IN PATIENTS WITH BONE METASTATIC PROSTATE CANCER AND HORMONE REFRACTORY DISEASE: PREDICTIVE ROLE OF BONE RESORPTION AND FORMATION MARKERS EVALUATED AT BASELINE. The Journal of Urology. 164(4). 1248–1253. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact